The Role of Sodium Bicarbonate as Adjuvant Treatment of Computed Tomography Identified COVID-19 Pneumonia

• Status: Active, not recruiting
• Trial end date: 2020-11-01
• Target enrollment: 0
• Participant gender: All

Summary

To report the possible role of S.B 8.4% in the treatment of COVID-19pneumonia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mansoura University

Criteria

Inclusion Criteria:

• Age >18 years.

• Fever ≥ 38º C with upper respiratory tract manifestations, generalized bone ache with or without gastrointestinal symptoms as diarrhea.

• Chest CT with signs suggestive of COVID-19.

• Mild and moderate cases of COVID-19 pneumonia with respiratory and hemodynamic stability. - High C reactive protein (CRP).- With or without history of contact with index case who is isolated in a governmental hospital assigned for treatment of patients proved to have RT-PCR positive test for COVID-19

• With or without abnormalities in the total or differential white cell count.

• Welling to sign a fully informed consent.

Exclusion Criteria:

• Severe and critical illness with respiratory failure and/ or hemodynamic instability.

• CT with pleural effusion with or without lung cavitation.

• Other organ failure.